BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26286429)

  • 1. Immunohistochemical Detection of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor in Canine Vascular Endothelial Tumours.
    Anwar Sh; Yanai T; Sakai H
    J Comp Pathol; 2015 Nov; 153(4):278-82. PubMed ID: 26286429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.
    Asa SA; Murai A; Murakami M; Hoshino Y; Mori T; Maruo K; Khater A; El-Sawak A; el-Aziz EA; Yanai T; Sakai H
    Histol Histopathol; 2012 May; 27(5):601-7. PubMed ID: 22419024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical analysis of canine haemangioma and haemangiosarcoma.
    Sabattini S; Bettini G
    J Comp Pathol; 2009; 140(2-3):158-68. PubMed ID: 19091326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the anti-apoptotic factors Bcl-2 and survivin in canine vascular tumours.
    Murakami M; Sakai H; Kodama A; Mori T; Maruo K; Yanai T; Masegi T
    J Comp Pathol; 2008 Jul; 139(1):1-7. PubMed ID: 18479697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodetection of the signal transducer and activator of transcription-3 in canine haemangioma and haemangiosarcoma.
    Petterino C; Rossetti E; Drigo M
    Res Vet Sci; 2006 Apr; 80(2):186-8. PubMed ID: 16098550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of the Akt/mTOR/4E-BP1 signalling pathway in canine haemangiomas and haemangiosarcomas.
    Murai A; Abou Asa S; Kodama A; Sakai H; Hirata A; Yanai T
    J Comp Pathol; 2012 Nov; 147(4):430-40. PubMed ID: 22789858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
    Wang L; Madigan MC; Chen H; Liu F; Patterson KI; Beretov J; O'Brien PM; Li Y
    Gynecol Oncol; 2009 Aug; 114(2):265-72. PubMed ID: 19450871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
    Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
    Ulisse S; Baldini E; Sorrenti S; Barollo S; Gnessi L; Catania A; Pellizzo MR; Nardi F; Mian C; De Antoni E; D'Armiento M; Frati L
    J Clin Endocrinol Metab; 2011 Feb; 96(2):504-8. PubMed ID: 21106716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases.
    Illemann M; Bird N; Majeed A; Laerum OD; Lund LR; Danø K; Nielsen BS
    Int J Cancer; 2009 Apr; 124(8):1860-70. PubMed ID: 19123477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis].
    Wang WC; Wang Y; Sun CJ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):257-60. PubMed ID: 12536699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of urokinase-type plasminogen activator and its receptor in neointima of polyester vascular grafts.
    Kowalewski R; Zimnoch L; Wojtukiewicz MZ; Glowinski J; Glowinski S
    Pathophysiol Haemost Thromb; 2005; 34(1):23-8. PubMed ID: 16293982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of urokinase-type plasminogen activator (uPA) and uPA receptor (uPAR) plays a role in destruction of joint tissue in rapidly destructive coxarthropathy (RDC)].
    Tamura N; Uzuki M; Matsumoto F; Rikimaru A; Kokubun S; Sawai T
    Ryumachi; 2001 Oct; 41(5):851-7. PubMed ID: 11729663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urokinase plasminogen activator system in angiosarcoma, Kaposi's sarcoma, granuloma pyogenicum, and angioma: an immunohistochemical study.
    Thewes M; Elsner E; Wessner D; Engst R; Ring J
    Int J Dermatol; 2000 Mar; 39(3):188-91. PubMed ID: 10759957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of vacuum-assisted closure on the expression of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in acute and chronic wounds healing].
    Li YJ; Cao DY; Chen SZ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2006 Jul; 22(4):306-9. PubMed ID: 17017150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
    Fox SB; Taylor M; Grøndahl-Hansen J; Kakolyris S; Gatter KC; Harris AL
    J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
    Cantero D; Friess H; Deflorin J; Zimmermann A; Bründler MA; Riesle E; Korc M; Büchler MW
    Br J Cancer; 1997; 75(3):388-95. PubMed ID: 9020484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer.
    Kimura S; D'Andrea D; Iwata T; Foerster B; Janisch F; Parizi MK; Moschini M; Briganti A; Babjuk M; Chlosta P; Karakiewicz PI; Enikeev D; Rapoport LM; Seebacher V; Egawa S; Abufaraj M; Shariat SF
    World J Urol; 2020 Oct; 38(10):2501-2511. PubMed ID: 31797075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.